Abstract
The ability of a number of cholinomimetic drugs to inhibit nociceptive responses in several animal species is well documented. Cholinomimetic agents which have shown antinociceptive activity in a variety of tests include the following: oxotremorine (16,19,26,32, 37,38,42), tremorine (7), arecoline (23,25,29,37,44), pilocarpine (10,25,29) and physostigmine (10,20,22,28,34,42,44,49). The specific central muscarinic mediation of these antinociceptive effects is agreed upon by most authors (10,25,28,37). Cholinomimetic drugs also potentiate narcotic analgesia in laboratory animals (1,26,28, 29,42,46,56) and in man (8,15,40,50,54). However, the relationship of cholinomimetic to narcotic analgesia remains unclear. Both classes of drugs demonstrate antinociceptive activity in similar tests and tolerance to each has been noted (see 48,55; also 10,26, 34). Significant cross-tolerance between narcotics and cholinomimetics has not been observed. Investigations into the possible inhibition of cholinergic antinociception by narcotic antagonists (7,18,20,26-28,42) and, conversely, the inhibition of narcotic analgesia by muscarinic receptor blockers (3,7,8,10,27-29,56) have yielded mixed results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bhargava, H.N. and Way, E.L. (1972): J. Pharmacol. Exp. Ther. 183:31–40.
Calcutt, C.R., Handley, S.L., Sparkes, C.G. and Spencer, P.S. J. (1972): IN Agonist and Antagonist Actions of Narcotic Analgesic Drugs, (eds) H.W. Kosterlitz, H.O.J. Collier and J.E Villarreal, MacMillan Press, London, pp. 176–191.
Câlcutt, C.R. and Spencer, P.S.J. (1972): Brit. J. Pharmacol. 41:401P-402P.
Cardenas, H.L. and Ross, D.H. (1975): J. Neurochem. 24:487–493.
Carlsson, A., Lindqvist, M., Fuxe, K. and Hokfelt, T. (1966): J. Pharm. Pharmacol. 18:60–62.
Cerreta, K.V., Loh, H.H. and Way, E.L. (1977): Fed. Proc.36:943.
Chen, G. (1958): J. Pharmacol. Exp. Ther. 124:73–76.
Christensen, E.M. and Gross, E.G. (1948): J. Amer. Med. Assoc. 137:594–598.
D’Amour, F.E. and Smith, D.L. (1941): J. Pharmacol. Exp. Ther. 72: 74–79.
Dayton, H.E. and Garrett, R.L. (1973): Proc. Soc. Exp. Biol. Med. 142:1011–1013.
Dewey, W.L., Chau-Pham, T.T. and Cocolas, G.C. (1976): IN Opiates and Endogenous Opiate Peptides (ed). H.W. Kosterlitz, Elseview/North-Holland, Amsterdam, pp. 185–190.
Dewey, W.L., Cocolas, G., Daves, E. and Harris, L.S. (1975): Life Sei. 17:9–10.
Dewey, W.L., Harris, L.S., Howes, J.F. and Nuite, J.A. (1970): J. Pharmacol. Exp. Ther. 175:435–442
Dewey, W.L., Pedigo, N.W., Karbowski, M., Forbes, J. and Harris, L.S. (1976): IN Tissue Responses to Addictive Drugs, (eds) D.H. Ford and D.H. Clouet, Spectrum, New York, pp. 255–271.
Floodmark, S. and Wramner, T. (1945): Acta Physiol. Scand. 9:88–96.
George, R., Haslett, W.L. and Jenden, D.J. (1962): Life Sei. 1:361–363.
Handley, S.L. and Spencer, P.S.J. (1969): Brit. J. Pharmacol. 35:361P-362P.
Harris, L.S. and Dewey, W.L. (1972): IN Agonist and Antagonist Actions of Narcotic Analgesic Drugs (eds) H.W. Kosterlitz, H.O.J. Collier and J.E. Villarreal, MacMillan Press, London, pp. 198–206.
Harris, L.S., Dewey, W.L. and Howes, J.F. (1968): Fed. Proc. 27: 753.
Harris, L.S., Dewey, W.L., Howes, J.F., Kennedy, J.S. and Pars, H. (1969): J. Pharmacol. Exp. Ther. 169:17–22.
Harris, R.A., Loh, H.H. and Way, E.L. (1975): J. Pharmacol. Exp. Ther. 195:488–498.
Hendershot, L.C. and Forsaith, J. (1959): J. Pharmacol. Exp. Ther. 125:237–240.
Herz, A. (1962): Arch. Exp. Pathol. Pharmakol. 242:414–429.
Holzbauer, M. and Vogt, M. (1956): J. Neurochem. 1:8–11.
Houser, V.P. (1976): Pharmacol. Biochem. Behav. 1:561–568.
Howes, J.F., Harris, L.S., Dewey, W.L. and Voyda, C.A. (1969): J. Pharmacol. Exp. Ther. 169:23–28.
Ireson, J.D. (1969): Brit. J. Pharmacol. 37:504P-505P.
Ireson, J.D. (1970): Brit. J. Pharmacol. 40:92–101.
Kaakkola, S. and Ahtee, L. (1977): Psychopharmacology 52:7–15.
Kakunga, T., Kaneto, H. and Hano, K. (1966): J. Pharmacol. Exp. Ther. 153:134–141.
Lee, R.L., Sewell, R.D.E. and Spencer, P.S.J. (1979): Neuropharmacology 18:711–717.
Leslie, G.B. (1969): J. Pharm. Pharmacol. 21:248–250.
Litchfield, S.T. and Wilcoxin, F. (1949): J. Pharmacol. Exp. Ther. 96:99–113.
Little, H.J. and Rees, J.M.H. (1974): Experientia 30:930–932.
Mayer, D.J. and Price, D.D. (1976): Pain 2:379–404.
McBride, W.J., Penn, P.E., Hyde, T.P., Lane, J.D. and Smith, J.E. (1976): Neurochem. Res. 2:437–449.
Metys, J., Wagner, N., Metysova, J. and Herz, A. (1969): Int. J. Neuropharmacol. 8:413–425.
Paalzow, G. and Paalzow, L. (1975): Eur. J. Pharmacol. 31: 261–272.
Pedigo, N.W., Dewey, W.L. and Harris, L.S. (1975): J. Pharmacol. Exp. Ther. 193:845–852.
Pellanda, C.L. (1933): Lyon Med. 151:653.
Pletscher, A., Shore, P.A. and Brody, B.B. (1956): J. Pharmacol. Exp. Ther. 116:84–89.
Pleuvry, B.J. and Tobias, M.A. (1971): Brit. J. Pharmacol. 43:706–714.
Quinn, G.P., Shore, P.A. and Brodie, B.B. (1959): J. Pharmacol. Exp. Ther. 127:103–109.
Ramabadran, K. and Jacob, J.J.C. (1978): Arch. Int. Pharmacodyn. Ther. 236:27–42.
Ross, D.H., Lynn, S.C. and Cardenas, H.L. (1977): IN Alcohol and Opiates, NeurochemicalandBehavioral Mechanisms, (ed) K. Blum, Academic Press, New York, pp. 265–281.
Saxena, P.N. and Gupta, G.P. (1957): Indian J. Med. Res. 45:319–325.
Schild, H.O. (1957): Pharmacol. Rev. 9:242–246.
Shuster, L. (1971): IN Narcotic Drugs: Biochemical Pharmacology (ed) D.H. Clouet, Plenum Press, New York, pp. 408–423.
Sitaram, N., Buchsbaum, M.S. and Gillin, J.C. (1977): Eur. J. Pharmacol. 42:285–290.
Slaughter, D. and Munsell, D. (1940): J. Pharmacol. Exp. Ther. 68:104–112.
Smits, S.E. and Takemori, A.E. (1970): Brit. J. Pharmacol. 39:627–638.
Sparkes, C.G. and Spencer, P.S.J. (1971): Brit. J. Pharmacol. 42:230–241.
Spector, S., Sjoerdsma, A. and Udenfriend, S. (1965): J. Pharmacol. Exp. Ther. 147:86–95.
Szerb, J.C. (1957): Arch. Int. Pharmacodyn. Ther. 111:314–321.
Takemori, A.E., (1975): Biochem. Pharmacol. 24:2121–2126.
Takemori, A.E., Tulunay, F.C. and Yano, I. (1975): IN The Opiate Narcotics, Intl. Narcotic Res. Club Conf., Pergamon Press, New York, pp. 175–181.
Tulunay, F.C. and Takemori, A.E. (1974): J. Pharmacol. Exp. Ther. 190:401–407.
Way, E.L. and Shen, F.H. (1971): IN Narcotic Drugs: Biochemical Pharmacology (ed) D.H. Clouet, Plenum Press, New York, pp. 229–253.
Widman, M., Rosin, D. and Dewey, W.L.(1978): J. Pharmacol. Exp. Ther. 205:311–318.
Yaksh, T.I., Frederickson, R.C.A., Huang, S.P. and Rudy, T.A. (1978): Brain Res. 148:516–520.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Pedigo, N.W., Dewey, W.L. (1981). Acetylcholine Induced Antinociception: Comparisons to Opiate Analgesia. In: Pepeu, G., Ladinsky, H. (eds) Cholinergic Mechanisms. Advances in Behavioral Biology, vol 25. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8643-8_78
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8643-8_78
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8645-2
Online ISBN: 978-1-4684-8643-8
eBook Packages: Springer Book Archive